Finance

Lists
Why is 300436 down 2,06%?
Dive Deeper
300436:SHE
Fujian Cosunter Pharmaceutical Co Ltd
80,00 CN¥
-2,06%
(-1,68) 1D
16-окт., 15:04:37 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300436...
Open
82,09 CN¥
High
85,89 CN¥
Low
79,83 CN¥
Mkt. cap
13,44 млд
Avg. vol.
2,69 млн
Volume
4,57 млн
52-wk high
149,00 CN¥
52-wk low
73,60 CN¥
EPS
-1,38 CN¥
Shares outstanding
168,03 млн
No. of employees
715
Open
82,09 CN¥
High
85,89 CN¥
Low
79,83 CN¥
Mkt. cap
13,44 млд
Avg. vol.
2,69 млн
Volume
4,57 млн
52-wk high
149,00 CN¥
52-wk low
73,60 CN¥
EPS
-1,38 CN¥
Shares outstanding
168,03 млн
No. of employees
715
News stories
From web sources and news partners
About Fujian Cosunter Pharmaceutical Co Ltd
CEO-
Employees715
Founded1999
Headquarters-
SectorPharmaceutical industry
Websitecosunter.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
106,98 млн
100,54 млн
98,44 млн
121,71 млн
Cost of goods sold
32,68 млн
71,64 млн
32,53 млн
74,28 млн
Cost of revenue
32,68 млн
71,64 млн
32,53 млн
74,28 млн
Research and development expenses
12,80 млн
4,28 млн
13,49 млн
9,40 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85,44 млн
78,09 млн
69,44 млн
72,06 млн
Operating expense
100,11 млн
85,32 млн
83,15 млн
85,73 млн
Total operating expenses
132,79 млн
156,96 млн
115,68 млн
160,01 млн
Operating income
-25,81 млн
-56,43 млн
-17,24 млн
-38,29 млн
Other non operating income
-987,89 миң
768,31 миң
-72,70 миң
-220,40 миң
EBT including unusual items
-44,63 млн
-122,10 млн
-27,04 млн
-41,74 млн
EBT excluding unusual items
-37,13 млн
-64,23 млн
-25,93 млн
-47,53 млн
Income tax expense
3,86 млн
835,64 миң
3,08 млн
4,16 млн
Effective tax rate
-8,64%
-0,68%
-11,38%
-9,97%
Other operating expenses
1,75 млн
2,27 млн
-90,80 миң
4,35 млн
Net income
-44,90 млн
-106,26 млн
-25,92 млн
-42,21 млн
Net profit margin
-41,97%
-105,70%
-26,34%
-34,68%
Earnings per share
-
-
-
-
Interest and investment income
13,03 миң
30,43 миң
134,30 миң
-
Interest expense
-8,30 млн
-7,88 млн
-8,75 млн
-9,10 млн
Net interest expenses
-8,29 млн
-7,85 млн
-8,62 млн
-9,10 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,17 млн
-33,43 млн
5,76 млн
-19,57 млн
Gain or loss from assets sale
-
-9,89 миң
-
201,00
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору